CNO CNO Financial Group, Inc.
Accident & Health Insurance · NYSE · SEC CIK 1224608 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q42025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-04-30 | 2025Q12025-03-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.09B | $1.29B | $1.03B | $1.14B | $1.19B | $1.15B | — | $1.00B |
| Operating income | $220.20M | $151.00M | $129.90M | $173.50M | $162.80M | $112.30M | — | $104.60M |
| Interest expense | $58.10M | $55.30M | $50.90M | $53.20M | $56.60M | $59.10M | — | $62.00M |
| Pretax income | $226.40M | $159.70M | $48.40M | $111.40M | $36.20M | $118.00M | — | $27.80M |
| Income tax | $65.30M | $33.80M | $10.70M | $3.40M | $13.10M | $26.20M | — | $6.30M |
| Net income | $161.10M | $125.90M | $37.70M | $92.90M | $23.10M | $91.80M | — | $21.50M |
| EBITDA | $305.00M | $235.10M | $213.30M | $255.30M | $242.90M | $191.10M | — | $182.40M |
| EPS (basic) | 1.75 | 1.35 | 0.40 | 0.98 | 0.24 | 0.93 | — | 0.21 |
| EPS (diluted) | 1.71 | 1.33 | 0.39 | 0.95 | 0.24 | 0.91 | — | 0.21 |
| Dividends declared per share | 0.18 | 0.18 | 0.17 | 0.17 | 0.17 | 0.17 | 0.16 | 0.16 |
| Weighted avg. shares (diluted) | 94.25M | 94.95M | 96.14M | — | 98.55M | 100.39M | — | 103.07M |
| Balance sheet | ||||||||
| Cash & equivalents | $1.42B | $1.31B | $1.15B | $983.50M | $1.24B | $816.00M | — | $1.02B |
| Goodwill | — | — | — | — | $69.50M | — | — | — |
| Total assets | $39.31B | $39.86B | $38.96B | $38.79B | $38.30B | $37.33B | — | $37.44B |
| Total liabilities | $36.98B | $37.27B | $36.47B | $36.15B | $35.69B | $34.81B | — | $34.91B |
| Shareholders' equity | $2.32B | $2.59B | $2.50B | $2.64B | $2.61B | $2.52B | — | $2.56B |
| Shares outstanding | 91.71M | 92.70M | 93.80M | 94.48M | 95.84M | 97.32M | — | 99.89M |
| Cash flow statement | ||||||||
| Operating cash flow | $242.00M | $156.60M | $148.80M | $195.70M | $197.80M | $145.50M | — | $136.70M |
| Investing cash flow | -$468.30M | -$603.70M | -$184.10M | -$900.80M | -$106.10M | -$122.20M | — | -$538.20M |
| Financing cash flow | $341.70M | $598.80M | $206.10M | $447.00M | $333.90M | -$232.10M | — | -$571.40M |
| Depreciation & amortization | $84.80M | $84.10M | $83.40M | $81.80M | $80.10M | $78.80M | — | $77.80M |
| Dividends paid | $16.60M | $16.70M | $17.10M | $16.20M | $16.40M | $16.70M | — | $16.90M |
| Share buybacks | $59.50M | $60.90M | $73.30M | $60.20M | $60.60M | $100.30M | — | $110.30M |
Free plan shows the latest 8 periods; Pro shows all 80 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.